Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Cell and Gene Therapy Catapult Appoints Board Members

This article was originally published in Scrip

Executive Summary

The UK organization Cell and Gene Therapy Catapult has appointed new non-executive directors Fiona Watt, Susan Foden and Steven Chatfield to its board. Watt has spent 20 years at the CRUK London Research Institute and helped establish the CRUK Cambridge Research Institute and Wellcome Trust Centre for stem cell research in Cambridge. Foden has been a non-executive director for various life science companies and currently holds non-executive positions at companies including British Technology Group plc., Vectura plc., Evgen Pharma plc and BerGenBio AS. Chatfield brings over 35 years' experience and previously held executive positions at the Health Protection Agency, Emergent BioSolutions, Microscience Ltd, Medeva plc, Evans Medical and Wellcome Biotechnology.

Advertisement
Advertisement
UsernamePublicRestriction

Register

SC064723

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel